Jingmin Shu

1.3k total citations
13 papers, 947 citations indexed

About

Jingmin Shu is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Jingmin Shu has authored 13 papers receiving a total of 947 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 2 papers in Pathology and Forensic Medicine and 2 papers in Hematology. Recurrent topics in Jingmin Shu's work include Epigenetics and DNA Methylation (9 papers), Cancer-related gene regulation (4 papers) and Acute Myeloid Leukemia Research (2 papers). Jingmin Shu is often cited by papers focused on Epigenetics and DNA Methylation (9 papers), Cancer-related gene regulation (4 papers) and Acute Myeloid Leukemia Research (2 papers). Jingmin Shu collaborates with scholars based in United States, United Kingdom and Japan. Jingmin Shu's co-authors include Jean‐Pierre J. Issa, Jaroslav Jelı́nek, Taichun Qin, Jiali Si, Lanlan Shen, Saira Ahmed, Han Y. H. Chen, Robert A. Waterland, Jiexin Zhang and Yutaka Kondo and has published in prestigious journals such as Nucleic Acids Research, Blood and PLoS ONE.

In The Last Decade

Jingmin Shu

13 papers receiving 924 citations

Peers

Jingmin Shu
Brian Freie United States
Rodolphe F. Taby United States
Jason E. Farrar United States
Daniel P. Sejas United States
Sean F. Landrette United States
Corrado Caslini United States
Francesco Boccalatte United States
Joanne I. Hsu United States
Brian Freie United States
Jingmin Shu
Citations per year, relative to Jingmin Shu Jingmin Shu (= 1×) peers Brian Freie

Countries citing papers authored by Jingmin Shu

Since Specialization
Citations

This map shows the geographic impact of Jingmin Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingmin Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingmin Shu more than expected).

Fields of papers citing papers by Jingmin Shu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingmin Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingmin Shu. The network helps show where Jingmin Shu may publish in the future.

Co-authorship network of co-authors of Jingmin Shu

This figure shows the co-authorship network connecting the top 25 collaborators of Jingmin Shu. A scholar is included among the top collaborators of Jingmin Shu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingmin Shu. Jingmin Shu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Rahrmann, Eric P., Natalie K. Wolf, George M. Otto, et al.. (2018). Sleeping Beauty Screen Identifies RREB1 and Other Genetic Drivers in Human B-cell Lymphoma. Molecular Cancer Research. 17(2). 567–582. 14 indexed citations
2.
Shu, Jingmin, Lihua Li, Anne E. Sarver, et al.. (2016). Imprinting defects at human 14q32 locus alters gene expression and is associated with the pathobiology of osteosarcoma. Oncotarget. 7(16). 21298–21314. 15 indexed citations
3.
Qin, Taichun, Jiali Si, Noël J.‐M. Raynal, et al.. (2015). Epigenetic synergy between decitabine and platinum derivatives. Clinical Epigenetics. 7(1). 97–97. 31 indexed citations
4.
Shu, Jingmin, et al.. (2014). HomeRun Vector Assembly System: A Flexible and Standardized Cloning System for Assembly of Multi-Modular DNA Constructs. PLoS ONE. 9(6). e100948–e100948. 11 indexed citations
5.
Shu, Jingmin, Zhilian Xia, Lihua Li, et al.. (2012). Dose-dependent differential mRNA target selection and regulation by let-7a-7f and miR-17-92 cluster microRNAs. RNA Biology. 9(10). 1275–1287. 66 indexed citations
6.
Zhang, Yan, Jingmin Shu, Jiali Si, et al.. (2012). Repetitive elements and enforced transcriptional repression co-operate to enhance DNA methylation spreading into a promoter CpG-island. Nucleic Acids Research. 40(15). 7257–7268. 23 indexed citations
7.
Qin, Taichun, Ryan Castoro, Jaroslav Jelı́nek, et al.. (2011). Mechanisms of Resistance to Decitabine in the Myelodysplastic Syndrome. PLoS ONE. 6(8). e23372–e23372. 109 indexed citations
8.
Shu, Jingmin, Betsy T. Kren, Zhilian Xia, et al.. (2011). Genomewide microRNA down-regulation as a negative feedback mechanism in the early phases of liver regeneration. Hepatology. 54(2). 609–619. 61 indexed citations
9.
Si, Jiali, Yanis Boumber, Jingmin Shu, et al.. (2010). Chromatin Remodeling Is Required for Gene Reactivation after Decitabine-Mediated DNA Hypomethylation. Cancer Research. 70(17). 6968–6977. 58 indexed citations
10.
Qin, Taichun, Jaroslav Jelı́nek, Jiali Si, Jingmin Shu, & Jean‐Pierre J. Issa. (2008). Mechanisms of resistance to 5-aza-2′-deoxycytidine in human cancer cell lines. Blood. 113(3). 659–667. 191 indexed citations
11.
Shen, Lanlan, Yutaka Kondo, Yi Guo, et al.. (2007). Genome-Wide Profiling of DNA Methylation Reveals a Class of Normally Methylated CpG Island Promoters. PLoS Genetics. 3(10). e181–e181. 284 indexed citations
12.
Shu, Jingmin, Jaroslav Jelı́nek, Hao Chang, et al.. (2006). Silencing of Bidirectional Promoters by DNA Methylation in Tumorigenesis. Cancer Research. 66(10). 5077–5084. 80 indexed citations
13.
Shen, Lanlan, Yutaka Kondo, Yi Guo, et al.. (2005). Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters. PLoS Genetics. preprint(2007). e181–e181. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026